Advertisement
Screener

Adicet Bio, Inc. (ACET) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

Adicet Bio, Inc. Interest Expense

Adicet Bio, Inc. (ACET) reported Interest Expense of $22.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2026-08-05

  • Adicet Bio, Inc. interest expense for the quarter ending 2026-06-30 was $22.00K.
  • Adicet Bio, Inc. interest expense for the quarter ending 2026-03-31 was $23.00K.
  • Adicet Bio, Inc. interest expense for the quarter ending 2025-12-31 was $24.00K, a 2300.00% increase year-over-year.
  • Adicet Bio, Inc. interest expense for the quarter ending 2025-09-30 was $12.00K, a 1100.00% increase year-over-year.
  • Adicet Bio, Inc. interest expense for fiscal 2025 was $36.00K, a 800.00% increase from fiscal 2024.
  • Adicet Bio, Inc. interest expense for fiscal 2024 was $4.00K, a 84.00% decline from fiscal 2023.
  • Adicet Bio, Inc. interest expense for fiscal 2023 was $25.00K, a 68.75% decline from fiscal 2022.
  • Adicet Bio, Inc. interest expense for fiscal 2022 was $80.00K, a 54.55% decline from fiscal 2021.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2026-06-30$22.00K
10-Q · filed 2026-08-05
$45.00K
10-Q · filed 2026-08-05
$69.00K
derived: sum of 3 quarters · filed 2026-08-05
$81.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$23.00K
10-Q · filed 2026-05-13
$47.00K
derived: sum of 2 quarters · filed 2026-05-13
$59.00K
derived: sum of 3 quarters · filed 2026-05-13
$59.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$36.00K
derived: sum of 2 quarters · filed 2026-03-12
$36.00K
derived: sum of 3 quarters · filed 2026-08-05
$36.00K
10-K · filed 2026-03-12
2025-09-30$12.00K
10-Q · filed 2025-11-05
$12.00K
derived: sum of 2 quarters · filed 2026-08-05
$12.00K
10-Q · filed 2025-11-05
$13.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$0.00
10-Q · filed 2026-08-05
$0.00
10-Q · filed 2026-08-05
$1.00K
derived: sum of 3 quarters · filed 2026-08-05
$2.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$0.00
10-Q · filed 2026-05-13
$1.00K
derived: sum of 2 quarters · filed 2026-05-13
$2.00K
derived: sum of 3 quarters · filed 2026-05-13
$2.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$2.00K
derived: sum of 2 quarters · filed 2026-03-12
$2.00K
derived: sum of 3 quarters · filed 2026-03-12
$4.00K
10-K · filed 2026-03-12
2024-09-30$1.00K
10-Q · filed 2025-11-05
$1.00K
derived: sum of 2 quarters · filed 2025-11-05
$3.00K
10-Q · filed 2025-11-05
$3.00K
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$0.00
10-Q · filed 2025-08-07
$2.00K
10-Q · filed 2025-08-07
$2.00K
derived: sum of 3 quarters · filed 2025-08-07
$3.00K
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$2.00K
10-Q · filed 2025-05-06
$2.00K
derived: sum of 2 quarters · filed 2025-05-06
$3.00K
derived: sum of 3 quarters · filed 2025-05-06
$7.00K
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$1.00K
derived: sum of 2 quarters · filed 2025-03-06
$5.00K
derived: sum of 3 quarters · filed 2025-03-06
$25.00K
10-K · filed 2025-03-06
2023-09-30$1.00K
10-Q · filed 2024-11-06
$5.00K
derived: sum of 2 quarters · filed 2024-11-06
$25.00K
10-Q · filed 2024-11-06
$50.00K
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30$4.00K
10-Q · filed 2024-08-13
$23.00K
10-Q · filed 2024-08-13
$49.00K
derived: sum of 3 quarters · filed 2024-08-13
$67.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$19.00K
10-Q · filed 2024-05-14
$45.00K
derived: sum of 2 quarters · filed 2024-05-14
$63.00K
derived: sum of 3 quarters · filed 2024-05-14
$81.00K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$26.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$44.00K
derived: sum of 2 quarters · filed 2024-03-19
$62.00K
derived: sum of 3 quarters · filed 2024-03-19
$80.00K
10-K · filed 2024-03-19
2022-09-30$18.00K
10-Q · filed 2023-11-08
$36.00K
derived: sum of 2 quarters · filed 2023-11-08
$54.00K
10-Q · filed 2023-11-08
$79.00K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$18.00K
10-Q · filed 2023-08-09
$36.00K
10-Q · filed 2023-08-09
$61.00K
derived: sum of 3 quarters · filed 2023-08-09
$111.00K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$18.00K
10-Q · filed 2023-05-09
$43.00K
derived: sum of 2 quarters · filed 2023-05-09
$93.00K
derived: sum of 3 quarters · filed 2023-05-09
$144.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$75.00K
derived: sum of 2 quarters · filed 2023-03-15
$126.00K
derived: sum of 3 quarters · filed 2023-03-15
$176.00K
10-K · filed 2023-03-15
2021-09-30$50.00K
10-Q · filed 2022-11-08
$101.00K
derived: sum of 2 quarters · filed 2022-11-08
$151.00K
10-Q · filed 2022-11-08
$201.00K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$51.00K
10-Q · filed 2022-08-10
$101.00K
10-Q · filed 2022-08-10
$151.00K
derived: sum of 3 quarters · filed 2022-08-10
$201.00K
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$50.00K
10-Q · filed 2022-05-12
$100.00K
derived: sum of 2 quarters · filed 2022-05-12
$150.00K
derived: sum of 3 quarters · filed 2022-05-12
$184.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$50.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$100.00K
derived: sum of 2 quarters · filed 2022-03-15
$134.00K
derived: sum of 3 quarters · filed 2022-03-15
$134.00K
10-K · filed 2022-03-15
2020-09-30$50.00K
10-Q · filed 2021-11-10
$84.00K
derived: sum of 2 quarters · filed 2021-11-10
$84.00K
10-Q · filed 2021-11-10
2020-06-30$34.00K
10-Q · filed 2021-08-12
$34.00K
10-Q · filed 2021-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Valion Bio, Inc. (VBIO)United States$0.077B
Lifevantage Corp (LFVN)United States$0.078B15.40
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41